1. Home
  2. SKYQ vs CING Comparison

SKYQ vs CING Comparison

Compare SKYQ & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYQ
  • CING
  • Stock Information
  • Founded
  • SKYQ 2019
  • CING 2012
  • Country
  • SKYQ United States
  • CING United States
  • Employees
  • SKYQ N/A
  • CING N/A
  • Industry
  • SKYQ
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKYQ
  • CING Health Care
  • Exchange
  • SKYQ NYSE
  • CING Nasdaq
  • Market Cap
  • SKYQ 13.5M
  • CING 13.1M
  • IPO Year
  • SKYQ N/A
  • CING 2021
  • Fundamental
  • Price
  • SKYQ $0.65
  • CING $4.11
  • Analyst Decision
  • SKYQ
  • CING Strong Buy
  • Analyst Count
  • SKYQ 0
  • CING 3
  • Target Price
  • SKYQ N/A
  • CING $16.00
  • AVG Volume (30 Days)
  • SKYQ 43.0K
  • CING 75.2K
  • Earning Date
  • SKYQ 05-14-2025
  • CING 05-07-2025
  • Dividend Yield
  • SKYQ N/A
  • CING N/A
  • EPS Growth
  • SKYQ N/A
  • CING N/A
  • EPS
  • SKYQ N/A
  • CING N/A
  • Revenue
  • SKYQ $23,364,188.00
  • CING N/A
  • Revenue This Year
  • SKYQ N/A
  • CING N/A
  • Revenue Next Year
  • SKYQ N/A
  • CING N/A
  • P/E Ratio
  • SKYQ N/A
  • CING N/A
  • Revenue Growth
  • SKYQ N/A
  • CING N/A
  • 52 Week Low
  • SKYQ $0.56
  • CING $1.80
  • 52 Week High
  • SKYQ $5.49
  • CING $20.83
  • Technical
  • Relative Strength Index (RSI)
  • SKYQ N/A
  • CING 50.72
  • Support Level
  • SKYQ N/A
  • CING $3.95
  • Resistance Level
  • SKYQ N/A
  • CING $4.44
  • Average True Range (ATR)
  • SKYQ 0.00
  • CING 0.28
  • MACD
  • SKYQ 0.00
  • CING 0.05
  • Stochastic Oscillator
  • SKYQ 0.00
  • CING 60.98

About SKYQ SKY QUARRY INC

Sky Quarry Inc is a development-stage oil-producing and refining company. The company along with its subsidiaries is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: